In Conversation

Fernando Fogarin – Strategic Project Lead Emerging Markets, Organon

Fernando Fogarin – Strategic Project Lead Emerging Markets, Organon

By addressing women's health, we positively impact the entire community. A healthy, empowered woman leads to a resilient family and a stronger society
Yu Wang – Chairman, Chinese Foundation for Hepatitis Prevention & Control

Yu Wang – Chairman, Chinese Foundation for Hepatitis Prevention & Control

The regulatory environment in China, guided by the NMPA, appears to be evolving positively, providing a conducive framework for pharmaceutical innovation and growth
NIH's Carl Dieffenbach on the Long Road to a HIV Vaccine

NIH's Carl Dieffenbach on the Long Road to a HIV Vaccine

My goal has been to try to develop strategies and approaches that – when implemented at scale – could really have an impact on HIV incidence
Eid Mansour – General Manager, Gilead Sciences Saudi Arabia

Eid Mansour – General Manager, Gilead Sciences Saudi Arabia

The country's environment is conducive to introducing innovative therapies, aligning perfectly with Gilead's mission. This alignment between the country's objectives and Gilead's goals was the tipping point that led us to establish our affiliate in the kingdom.
Diana Liu – General Manager, Roche Hong Kong & Macau

Diana Liu – General Manager, Roche Hong Kong & Macau

These three elements—expertise, quality, and efficiency—make Hong Kong a unique and valuable location for our clinical trials
Lionel Collet – President, Haute Autorité de Santé (HAS), France

Lionel Collet – President, Haute Autorité de Santé (HAS), France

Maintaining independence is paramount because we must never be beholden, in any way, to either industry interests or governmental influence.
Mohammed Khalil – CEO, SAJA Pharmaceuticals

Mohammed Khalil – CEO, SAJA Pharmaceuticals

Our goal is to ensure that the right medication is available at the right time and at a fair price
Sarah McMullen, Country Director, FDA India Office

Sarah McMullen, Country Director, FDA India Office

As the saying goes – “a rising tide lifts all boats”, and we would expect that universal implementation of GMPs would buoy product quality among those firms in compliance
Monica Bettencourt-Dias – Principal Investigator & Former Director, Gulbenkian Institute for Science (IGC)

Monica Bettencourt-Dias – Principal Investigator & Former Director, Gulbenkian Institute for Science (IGC)

The funding landscape for science in Portugal is facing challenges that stem from a decrease in overall investment and shifting priorities. Despite the evident role of blue-sky research, exemplified by important contributions to critical advancements like RNA vaccines, there has not been a corresponding increase in funding
See more

In Case You Missed It

InFigures

The top 10 pharma companies in Portugal ranked by sales value in both the hospital and pharmacy markets. These charts are from IQVIA and are based on a moving annual total up to October 2023. Household Big Pharma names like Janssen (recently rebranded as Johnson & Johnson Innovative Medicines), Roche, MSD, and Novartis dominate the…

After the Hong Kong Exchanges and Clearing Limited’s (HKEX) 2018 move to allow pre-revenue biotech companies to raise capital in Hong Kong under its Chapter 18A mechanism, biotech listings surged with pre-clinical companies chosing to list on HKEX as a means of accessing global capital, raising around HKD 118 billion in funding. After a record…

The world’s top 10 medical technology companies for 2022 according to Medical Product Outsourcing (MPO). Abbott leads the way, followed by Medtronic, J&J, and Siemens Healthineers. Recent PharmaBoardroom interviews with some of these companies’ leading executives include Hugo F. Villegas, SVP & President, Canada & Latin America at Medtronic, Eman Ali, Regional Vice President for…

Latin America will be the world’s fastest growing region for pharmaceuticals up to 2027, with a stunning expected compound annual growth rate of 22 percent, according to recent reporting from IQVIA. The Indian subcontinent can also expect sizeable growth over the next three years, although the US, Europe, and East Asia will remain the largest…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here